Dr. Jacob D. Soumerai, MD
Claim this profileMassachusetts General Hospital
Studies Lymphoma
Studies Lymphoid Leukemia
9 reported clinical trials
15 drugs studied
Area of expertise
1Lymphoma
TP53 positive
CD5 positive
CD19 positive
2Lymphoid Leukemia
TP53 positive
CD5 positive
CD19 positive
Affiliated Hospitals
Clinical Trials Jacob D. Soumerai, MD is currently running
JCAR017
for Chronic Leukemia or Lymphoma
This trial tests JCAR017, a therapy using modified immune cells, in adults with hard-to-treat CLL or SLL. It aims to see if these enhanced immune cells can better fight the cancer.
Recruiting1 award Phase 1 & 2
Triple Combo Therapy
for Chronic Lymphocytic Leukemia
The purpose of this study is to determine the rate of minimum residual disease (MRD) negative response (i.e. the rate of no evidence of disease) of the study drugs, zanubrutinib, obinutuzumab, and venetoclax, given in combination as a treatment for CLL and/or SLL.
Recruiting1 award Phase 216 criteria
More about Jacob D. Soumerai, MD
Clinical Trial Related7 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Jacob D. Soumerai, MD has experience with
- Venetoclax
- Acalabrutinib
- Obinutuzumab
- Umbralisib
- Belantamab Mafodotin
- Ublituximab
Breakdown of trials Jacob D. Soumerai, MD has run
Lymphoma
Lymphoid Leukemia
T-Lymphoblastic Leukemia/Lymphoma
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jacob D. Soumerai, MD specialize in?
Jacob D. Soumerai, MD focuses on Lymphoma and Lymphoid Leukemia. In particular, much of their work with Lymphoma has involved TP53 positive patients, or patients who are CD5 positive.
Is Jacob D. Soumerai, MD currently recruiting for clinical trials?
Yes, Jacob D. Soumerai, MD is currently recruiting for 4 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Jacob D. Soumerai, MD has studied deeply?
Yes, Jacob D. Soumerai, MD has studied treatments such as Venetoclax, Acalabrutinib, Obinutuzumab.
What is the best way to schedule an appointment with Jacob D. Soumerai, MD?
Apply for one of the trials that Jacob D. Soumerai, MD is conducting.
What is the office address of Jacob D. Soumerai, MD?
The office of Jacob D. Soumerai, MD is located at: Massachusetts General Hospital, Boston, Massachusetts 02114 United States. This is the address for their practice at the Massachusetts General Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.